131 related articles for article (PubMed ID: 34917942)
1.
Pfaller MA; Li L; Liu Q; Zhang J; Huband MD; Lindley JM; Mendes RE
JAC Antimicrob Resist; 2021 Dec; 3(4):dlab177. PubMed ID: 34917942
[TBL] [Abstract][Full Text] [Related]
2. Surveillance of omadacycline activity tested against clinical isolates from the United States and Europe: Results from the SENTRY Antimicrobial Surveillance Programme, 2017.
Huband MD; Pfaller MA; Shortridge D; Flamm RK
J Glob Antimicrob Resist; 2019 Dec; 19():56-63. PubMed ID: 30825698
[TBL] [Abstract][Full Text] [Related]
3.
Huband MD; Mendes RE; Pfaller MA; Lindley JM; Strand GJ; Benn VJ; Zhang J; Li L; Zhang M; Tan X; Liu Q; Flamm RK
Antimicrob Agents Chemother; 2020 Apr; 64(5):. PubMed ID: 32071042
[TBL] [Abstract][Full Text] [Related]
4. Activity of the Novel Aminomethylcycline KBP-7072 and Comparators against 1,057 Geographically Diverse Recent Clinical Isolates from the SENTRY Surveillance Program, 2019.
Huband MD; Thompson JD; Gurung ND; Liu Q; Li L; Zhang J; Streit JM; Castanheira M
Antimicrob Agents Chemother; 2022 Jan; 66(1):e0139721. PubMed ID: 34633850
[TBL] [Abstract][Full Text] [Related]
5.
Han R; Ding L; Yang Y; Guo Y; Yin D; Wu S; Zhi P; Zhu D; Liu Q; Tan X; Zhu Y; Zhang J; Li L; Hu F
Microbiol Spectr; 2022 Feb; 10(1):e0147121. PubMed ID: 35138143
[TBL] [Abstract][Full Text] [Related]
6. Antimicrobial activity of omadacycline in vitro against bacteria isolated from 2014 to 2017 in China, a multi-center study.
Xiao M; Huang JJ; Zhang G; Yang WH; Kong F; Kudinha T; Xu YC
BMC Microbiol; 2020 Nov; 20(1):350. PubMed ID: 33198626
[TBL] [Abstract][Full Text] [Related]
7. Surveillance of Omadacycline Activity Tested against Clinical Isolates from the United States and Europe: Report from the SENTRY Antimicrobial Surveillance Program, 2016 to 2018.
Pfaller MA; Huband MD; Shortridge D; Flamm RK
Antimicrob Agents Chemother; 2020 Apr; 64(5):. PubMed ID: 32071045
[TBL] [Abstract][Full Text] [Related]
8. In vitro activity of tigecycline, a new glycylcycline, tested against 1,326 clinical bacterial strains isolated from Latin America.
Gales AC; Jones RN; Andrade SS; Pereira AS; Sader HS
Braz J Infect Dis; 2005 Oct; 9(5):348-56. PubMed ID: 16410885
[TBL] [Abstract][Full Text] [Related]
9.
Zeng W; Zhang X; Liu Y; Zhang Y; Xu M; Wang S; Sun Y; Zhou T; Chen L
Front Microbiol; 2022; 13():1043736. PubMed ID: 36483205
[TBL] [Abstract][Full Text] [Related]
10. Surveillance of tigecycline activity tested against clinical isolates from a global (North America, Europe, Latin America and Asia-Pacific) collection (2016).
Pfaller MA; Huband MD; Streit JM; Flamm RK; Sader HS
Int J Antimicrob Agents; 2018 Jun; 51(6):848-853. PubMed ID: 29410368
[TBL] [Abstract][Full Text] [Related]
11. Omadacycline invitro activity against a molecularly characterized collection of clinical isolates with known acquired tetracycline resistance mechanisms.
Mendes RE; Huband MD; Streit JM; Castanheira M; Flamm RK
Diagn Microbiol Infect Dis; 2020 Jul; 97(3):115054. PubMed ID: 32376058
[TBL] [Abstract][Full Text] [Related]
12.
Mendes RE; Rhomberg PR; Lister T; Cotroneo N; Parr TR; Castanheira M
Antimicrob Agents Chemother; 2020 Dec; 65(1):. PubMed ID: 33077651
[TBL] [Abstract][Full Text] [Related]
13. Surveillance of omadacycline activity tested against clinical isolates from the USA: report from the SENTRY Antimicrobial Surveillance Program, 2019.
Pfaller MA; Huband MD; Shortridge D; Flamm RK
J Glob Antimicrob Resist; 2021 Dec; 27():337-351. PubMed ID: 34775129
[TBL] [Abstract][Full Text] [Related]
14. Activity of omadacycline tested against Streptococcus pneumoniae from a global surveillance program (2014).
Pfaller MA; Rhomberg PR; Huband MD; Flamm RK
Diagn Microbiol Infect Dis; 2018 Feb; 90(2):143-147. PubMed ID: 29157954
[TBL] [Abstract][Full Text] [Related]
15. Comparison of antibacterial activities and resistance mechanisms of omadacycline and tigecycline against Enterococcus faecium.
Liu X; Zhang C; Zhao Y; Cheng H; Wang Y; Wang Z; Shang Y; Zheng J; Yu Z; Shi Y
J Antibiot (Tokyo); 2022 Aug; 75(8):463-471. PubMed ID: 35760902
[TBL] [Abstract][Full Text] [Related]
16. KPC-producing Klebsiella pneumoniae bloodstream isolates from Brazilian hospitals: What (still) remains active?
Antochevis LC; Magagnin CM; Nunes AG; Goulart TM; Martins AS; CayƓ R; Gales AC; Barth AL; Zavascki AP
J Glob Antimicrob Resist; 2018 Dec; 15():173-177. PubMed ID: 30071353
[TBL] [Abstract][Full Text] [Related]
17. Comparative activities of sitafloxacin against recent clinical isolates in hospitals across China.
Wu S; Yang Y; Guo Y; Yin D; Zheng Y; Han R; Ding L; Zhu D; Hu F
Eur J Clin Microbiol Infect Dis; 2021 Nov; 40(11):2271-2283. PubMed ID: 34013453
[TBL] [Abstract][Full Text] [Related]
18.
Sun X; Zhang B; Xu G; Chen J; Shang Y; Lin Z; Yu Z; Zheng J; Bai B
Ann Lab Med; 2021 May; 41(3):293-301. PubMed ID: 33303714
[TBL] [Abstract][Full Text] [Related]
19.
Castanheira M; Davis AP; Mendes RE; Serio AW; Krause KM; Flamm RK
Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29866862
[TBL] [Abstract][Full Text] [Related]
20. Occurrence of tetracycline resistance genes among Escherichia coli isolates from the phase 3 clinical trials for tigecycline.
Tuckman M; Petersen PJ; Howe AY; Orlowski M; Mullen S; Chan K; Bradford PA; Jones CH
Antimicrob Agents Chemother; 2007 Sep; 51(9):3205-11. PubMed ID: 17620376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]